Fatih Tekin

Fatih Tekin

Auto-generated profile, based on publicly available information

Fatih Tekin

Hacettepe Univ, Fac Med, Dept Chest Dis, Ankara, Turkey

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2013 in Journal of Craniofacial Surgery
Verified
Journal Article
Closed access
CCCandemir Ceran
Candemir Ceran
MDMustafa Erol Demirseren
Mustafa Erol Demirseren
MSMurat Sarici
Murat Sarici
MDMustafa Durgun
Mustafa Durgun
FTFatih Tekin
Fatih Tekin
The reconstruction of intraoral defects can be challenging due to the different characteristics of the region, importance of preserving the anatomy and function, and shortage of available donor areas. The location and size of the defect guides the reconstructive surgeon through the treatment plan. Among the options available, tongue flaps have been found useful in intraoral defect reconstruction. In this study, we presented the use of tongue flaps in different kinds of intraoral defects, and compared the advantages and disadvantages with other methods. Between 2004 and 2011, tongue flaps were used in intraoral reconstruction of 11 patients (6 male and 5 female) with a mean age of 30.1. Six patients had palatal fistula, 3 had alveolar region and mouth floor defects, and 2 had lower lip defects. All of the tongue flaps planned were anterior based, 6 dorsal and 5 ventral. Second operations were carried out on the 15th or 20th postoperative days. Despite the disadvantages of being an interpolation flap which requires a second session and good patient cooperation, tongue flap is a choice for reconstruction of intraoral defects with its highly vascular structure, good mobility, localization, texture match, and low donor area morbidity.

1 January 2021 in Tuberk Toraks
Verified
Journal Article
Closed access
IIIlim Irmak
Ilim Irmak
FTFatih Tekin
Fatih Tekin
LÇLütfi Çöplü
Lütfi Çöplü
ZSZiya Toros Selçuk
Ziya Toros Selçuk
Introduction: Oxygen desaturation is a significant event during bronchoscopy. In this study, it was aimed to identify factors related to oxygen desaturation during flexible bronchoscopy (F13) and Fndobronchial ultrasound (EBUS). Materials and Methods: From 16 April 2019 to 14 February 2020, 196 consecutive patients (146 FB and 50 EBUS) undergoing bronchoscopy were evaluated retrospectively. The patients'oxygen saturations were monitored on admission and during the procedure by finger pulse oximetry. Desaturation was defined as saturation below 90%. Demographic characteristics, comorbidities, types of interventions, vitals before and during the procedure, amount of saturation decline, and sedative agents used were recorded. The data obtained were compared between the desaturated and non-desaturated groups in both FB and EBUS. We evaluated the risk factors for desaturation during bronchoscopic procedures. Results: The mean age of those who underwent FB was higher (62 152-681 years vs. 55 (44-651 years, p= 0.05), and males were more frequent (54%, vs 19.2%, p< 0.001) in the desaturated group. In FB, short lavage was more frequent in the non-desaturated group (28.8% vs. 9.5%, p< 0.001). In EBUS, hypertension, diabetes mellitus and thyroid diseases were higher, and duration of procedure was longer (p- 0.02, p= 0.04, p- 0.01 and p <0.001, respectively) in the desaturated group. In both FB and EBUS, baseline SpO(2) was lower (96% vs. 98% in FB, 97% vs. 98% in EBUS, p< 0.001 and p= 0.01, respectively), and SpO(2) decline during procedures was higher (11% vs. 1% in FB, 18% vs. 3% in EBUS, p< 0.001, each) in the desaturated group. Conclusion: This study suggested that baseline SpO(2) and SpO(2) decline during procedures as well as sex, hypertension, and concomitant endocrine - metabolic diseases, duration of procedure were factors associated with desaturation in patients who had undergone FB and EBUS.

1 January 2025 in Cancer Biomarkers
Verified
Journal Article
Open access
FTFatih Tekin
Fatih Tekin
DKDeniz Koksal
Deniz Koksal
ZDZ Gunnur Dikmen
Z Gunnur Dikmen
SKSevilay Karahan
Sevilay Karahan
RBRıdvan Bayler
Rıdvan Bayler
SOSevgen Onder
Sevgen Onder
Background and Aim: Malignant pleural effusion (MPE) is a common clinical problem. Management options are mainly pleurodesis and drainage, and have remained unchanged for years. Novel therapies that target the molecules responsible for fluid formation are needed to reduce the need for invasive procedures. The aim of this study is to investigate the potential role of MCP-1 in the development of MPE in patients with metastatic pleural malignancies. Methods: Pleural effusion samples (8–10 ml) were collected from 100 patients who were divided into three groups: Group 1 (MPE, n = 56), Group 2 (benign exudate, n = 27) and Group 3 (transudate, n = 17). The collected effusions were promptly centrifuged at 4°C, and the supernatants were stored at −80°C. MCP-1 levels were determined by ELISA kit (USCN, Wuhan). Results: Median MCP-1 levels were found to be significantly different between the three groups (Group 1: 1303 pg/ml, Group 2: 926 pg/ml, Group 3: 211 pg/ml) ( p < 0.001). MCP-1 levels were markedly higher but similar in Group 1 and Group 2, as compared to Group 3. When patients from Group 1 and Group 2 were combined, a positive correlation was observed between pleural fluid MCP-1 and LDH levels (r = 0.38; p = 0.001). Additionally, MCP-1 levels were observed to increase significantly as the volume of pleural fluid increased ( p = 0.007). Conclusion: MCP-1 levels were found to be similarly high in both Group 1 (MPE) and Group 2 (Benign exudate), indicating that inflammation accompanying the tumor could play a role in the formation of pleural effusion. This suggests that the development of biological therapies targeting MCP-1 could be a promising approach in the future management of MPE.

30 September 2024 in Acta Medica
Verified
Journal Article
Open access
PDF file
OKOğuz Karcıoğlu
Oğuz Karcıoğlu
FTFatih Tekin
Fatih Tekin
EOEbru Ozturk
Ebru Ozturk
SÖSevgen Önder
Sevgen Önder
ZSZiya Toros Selçuk
Ziya Toros Selçuk
Objective: Malignant pleural effusion (MPE) is indicative of advanced-stage disease and a poor prognosis in almost all cancer types. Lung and breast cancers are the predominant malignancies causing MPE, collectively representing over 60% of the total. In recent years, cancer has become a type of chronic disease, with advancements in diagnostic tools and treatment strategies. Our objective was to assess the evolution of primary diagnoses, survival rates, and associated variables among individuals with MPE in recent years. Materials and Methods: A retrospective search was conducted on the demographics, comorbidities, primary cancer sites, diagnostic interventions, and laboratory results of patients diagnosed with MPE between January 1, 2005, and July 30, 2018. Results: Of the 663 patients who have MPE, the female/male ratio was 373/290. The mean age was 59.2 ± 14.0 at the time of diagnosis. The most common cancers were lung cancer (30.9%), breast cancer (23.3%), and gastrointestinal system cancers (16.62%). It was observed that the rate of MPE due to lung cancer increased gradually over the years. Initially, breast cancer constituted the most prevalent diagnosis in 28.2% of cases, whereas lung cancer rose to the top as the most prevalent in the second and third five-year periods (28.9% and 37.4%, respectively). Overall, the median survival time was 2.07 months. Kaplan-Meier analysis also revealed that survival times did not change significantly over fourteen years. Conclusion: Advances in diagnostic methods and treatment modalities have altered the most common primary cancer causing MPE in recent years but have not contributed to survival time.

1 May 2022 in Turkish Thoracic Journal
Verified
Journal Article
Open access
IIIlim Irmak
Ilim Irmak
MIMaide Gozde Inam
Maide Gozde Inam
FTFatih Tekin
Fatih Tekin
EDEbru Damadoglu
Ebru Damadoglu
Contact with infected person,COVID-19 pneumonia,filiation method,severity of disease

31 December 2020 in Acta Medica
Verified
Journal Article
Open access
PDF file
IIİlIm Irmak
İlIm Irmak
SBSilam Bas
Silam Bas
MIMaide Gözde Inam
Maide Gözde Inam
FTFatih Tekin
Fatih Tekin
BYBerkay Yesilyurt
Berkay Yesilyurt
LCLütfi Coplu
Lütfi Coplu
Objective: The aim of the study is to describe the clinical characteristics of Antineutrophil cytoplasmic antibodies-associated vasculitis and to analyze the parameters affecting the outcome. Materials and Methods: The study is a retrospective cohort study. Totally 130 patients with Antineutrophil cytoplasmic antibodies-associated vasculitis (18 years and over) who were followed up between October 2014 and October 2019 were analyzed. Demographic data, laboratory values, clinical course, thorax computed tomography findings and treatment approaches were noted from the charts of patients. Patients were divided into two groups as those with pulmonary involvement and non-pulmonary involvement. Results: We retrospectively reviewed the medical records of 130 patients with Antineutrophil cytoplasmic antibodies-associated vasculitis; 111 with granulomatosis with polyangiitis, 15 with microscopic polyangiitis, 1 with eosinophilic granulomatosis with polyangiitis, and 3 with other types of vasculitis. The ratio of having the abnormality in thoracic computed tomography was 72.2%. There were 84 cases with pulmonary involvement and 46 cases with non-pulmonary involvement. The frequency of microscopic polyangiitis was significantly higher (p=0.034) in non-pulmonary involvement cases. There were 67 cases with proteinase 3 Antineutrophil cytoplasmic antibodies and 39 cases with myeloperoxidase Antineutrophil cytoplasmic antibodies positivity. Most of the cases with proteinase 3 Antineutrophil cytoplasmic antibodies positivity were classified as granulomatosis with polyangiitis, this was statistically significant. Recovery was referenced for the outcome. Any of the variables were found statistically significant effective on outcome. Conclusions: Cases with pulmonary involvement were more than the cases without pulmonary involvement in our study. microscopic polyangiitis was significantly higher in non- pulmonary involvement cases. We studied on a large group, and these significant findings may have important implications for the investigation, pathogenesis, and treatment of Antineutrophil cytoplasmic antibodies-associated vasculitis.